Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20090609002016N10Phase 3Completed
Phase 3, open-label trial of lidocaine and epinephrine (2 arms), sponsored by Kerman University of Medical Sciences. Primary endpoints: Injection pain and Anesthesia success. Started Nov 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20090609002016N10.